Wikidata

(Q43606242)

English

Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer.

scientific article

In more languages

Statements

title
Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
11350886
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11350886%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 November 2019
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43606242&oldid=2101860348"